Amgen (AMGN) Interest Coverage Ratio (2009 - 2026)
Amgen (AMGN) posted Interest Coverage Ratio of 5.22 for Q2 2026, up 28.67% on a QoQ basis from 4.06 in Q1 2026, and up 36.43% year-over-year from 3.83 in Q2 2025.
Analysis
Amgen (AMGN) Interest Coverage Ratio (2009 - 2026) Analysis & Trends
Amgen has reported Interest Coverage Ratio for 18 years, with the latest figure at 5.22 in Q2 2026.
- On a quarterly basis, Interest Coverage Ratio rose 36.43% year-over-year to 5.22 in Q2 2026; TTM through Jun 2026 was 4.28, a 53.7% increase from a year earlier, with the FY2025 full-year figure at 3.3, up 43.27% from the prior year.
- Interest Coverage Ratio was 5.22 for Q2 2026 at Amgen, up from 4.06 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 8.47 in Q1 2022, with the low at 1.2 in Q1 2024.
- Average Interest Coverage Ratio over 5 years is 3.94, with a median of 3.63 recorded in 2023.
- The sharpest annual moves came in 2023 and 2026: Interest Coverage Ratio tumbled 71.19% in 2023, then jumped 149.05% in 2026.
- Over 5 years, Interest Coverage Ratio stood at 5.37 in 2022, then sank by 71.19% to 1.55 in 2023, then surged by 99.84% to 3.09 in 2024, then soared by 34.64% to 4.17 in 2025, then rose by 25.35% to 5.22 in 2026.
- The last three Interest Coverage Ratio figures came in at 5.22 (Q2 2026), 4.06 (Q1 2026), and 4.17 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Insmed | 27.67 Bn | 26.51 Bn | 358.27 Mn | -0.08 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.22 |
| Mar 31, 2026 | 4.06 |
| Dec 31, 2025 | 4.17 |
| Sep 30, 2025 | 3.69 |
| Jun 30, 2025 | 3.83 |
| Mar 31, 2025 | 1.63 |
| Dec 31, 2024 | 3.09 |
| Sep 30, 2024 | 2.64 |
| Jun 30, 2024 | 2.36 |
| Mar 31, 2024 | 1.20 |
| Dec 31, 2023 | 1.55 |
| Sep 30, 2023 | 2.66 |
| Jun 30, 2023 | 3.57 |
| Mar 31, 2023 | 3.54 |
| Dec 31, 2022 | 5.37 |
| Sep 30, 2022 | 7.23 |
| Jun 30, 2022 | 6.63 |
| Mar 31, 2022 | 8.47 |
| Dec 31, 2021 | 6.88 |
| Sep 30, 2021 | 8.03 |